Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Surface Changes: Xalatan vs Travatan Z
NCT00798694Phase 4Completed
- Sponsor
- Wills Eye Hospital
- Start
- Nov 2008
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of latanoprost and travoprost in Glaucoma, sponsored by Wills Eye Hospital. Primary endpoint: Tear Break up Time at 2 months. Started Nov 2008; status: completed.
02
Drugs
latanoprosttravoprost
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00798694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798694.